Found: 30
Select item for more details and to access through your institution.
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants.
- Published in:
- Genes, 2024, v. 15, n. 3, p. 387, doi. 10.3390/genes15030387
- By:
- Publication type:
- Article
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 1, p. 30, doi. 10.3390/cells13010030
- By:
- Publication type:
- Article
Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5370, doi. 10.3390/cancers15225370
- By:
- Publication type:
- Article
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4747, doi. 10.3390/cancers15194747
- By:
- Publication type:
- Article
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1029, doi. 10.3390/cells12071029
- By:
- Publication type:
- Article
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1705, doi. 10.3390/ijms24021705
- By:
- Publication type:
- Article
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 4, p. 752, doi. 10.3390/cells11040752
- By:
- Publication type:
- Article
Efficacy of ixazomib-lenalidomidedexamethasone in high-molecular-risk relapsed/refractory multiple myeloma - case series and literature review.
- Published in:
- Annals of Agricultural & Environmental Medicine, 2022, v. 29, n. 1, p. 103, doi. 10.26444/aaem/137788
- By:
- Publication type:
- Article
The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5276, doi. 10.3390/jcm10225276
- By:
- Publication type:
- Article
Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2817, doi. 10.3390/cancers13112817
- By:
- Publication type:
- Article
Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2873, doi. 10.3390/cancers12102873
- By:
- Publication type:
- Article
High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2614, doi. 10.3390/cancers12092614
- By:
- Publication type:
- Article
The Association of GSTT1, GSTM1 , and TNF- α Polymorphisms With the Risk and Outcome in Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01056
- By:
- Publication type:
- Article
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 695, doi. 10.1111/bjh.15972
- By:
- Publication type:
- Article
Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5021, doi. 10.2147/CMAR.S191311
- By:
- Publication type:
- Article
ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00044
- By:
- Publication type:
- Article
Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
- Published in:
- Advances in Clinical & Experimental Medicine, 2018, v. 27, n. 12, p. 1683, doi. 10.17219/acem/75903
- By:
- Publication type:
- Article
Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.
- Published in:
- Oncology Letters, 2018, v. 15, n. 2, p. 1580, doi. 10.3892/ol.2017.7484
- By:
- Publication type:
- Article
TP53 polymorphism in plasma cell myeloma.
- Published in:
- Folia Histochemica et Cytobiologica, 2017, v. 55, n. 4, p. 203, doi. 10.5603/FHC.a2017.0022
- By:
- Publication type:
- Article
Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 4, p. 255, doi. 10.1159/000430980
- By:
- Publication type:
- Article
The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 9, p. 1121, doi. 10.1007/s00228-015-1893-0
- By:
- Publication type:
- Article
Metody genetyczne w diagnostyce hematoonkologicznej.
- Published in:
- Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej, 2015, v. 69, p. 475
- By:
- Publication type:
- Article
Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078091
- By:
- Publication type:
- Article
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 1, p. 41, doi. 10.1002/hon.2018
- By:
- Publication type:
- Article
JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.
- Published in:
- Folia Histochemica et Cytobiologica, 2011, v. 49, n. 2, p. 267, doi. 10.5603/FHC.2011.0037
- By:
- Publication type:
- Article
Assessment of the pathway of apoptosis involving PAR-4, DAXX and ZIPK proteins in CLL patients and its relationship with the principal prognostic factors.
- Published in:
- Folia Histochemica et Cytobiologica, 2011, v. 49, n. 1, p. 98, doi. 10.5603/FHC.2011.0014
- By:
- Publication type:
- Article
Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Assessment of Peripheral Blood and Bone Marrow Cells Apoptosis Caused by Purine Analogues in Patients with Chronic Lymphocytic Leukemia in Correlation with Parameters of Disease Progression.
- Published in:
- Acta Haematologica, 2010, v. 123, n. 3, p. 171, doi. 10.1159/000294961
- By:
- Publication type:
- Article